Brent McClellan Vaughan
Medical Practice in Salt Lake City, UT
License number
Utah 283564-6201
Issued Date
Dec 13, 1994
Expiration Date
Nov 30, 1998
Category
Health Care Assistant
Type
Health Care Assistant - Obsolete
Address
Address
Salt Lake City, UT
Personal information
See more information about Brent McClellan Vaughan at radaris.comName
Address
Phone
1104 E 260 N, Spanish Fork, UT 84660
12121 S Samson Cir, Draper, UT 84020
4398 6095, Salt Lake Cty, UT 84118
1104 260, Spanish Fork, UT 84660
4398 W 6095 S, Salt Lake City, UT 84118
Professional information
Brent Vaughan
Position:
Director, Health Information Services at 4Life Research, LC
Location:
Greater Salt Lake City Area
Industry:
Health, Wellness and Fitness
Work:
4Life Research, LC
since Nov 2004
-
Director, Health Information Services
Skills:
Public Speaking, Research Design, Dietetics, Formulation, Supplements, Nutrition, Sports Nutrition, Product Development, Research, GMP, Nutraceuticals, Wellness, Project Management, Strategic Planning, Healthcare, Entrepreneurship, Holistic Health, Management, Marketing, Fitness
Languages:
English, Cambodian, Spanish
Certifications:
Registered Dietitian, Commission of Dietetics
Methods And Systems For Assaying, Maintaining, And Enhancing The Activity Of The Immune System Of A Subject
US Patent:
2010029, Nov 25, 2010
Filed:
May 5, 2010
Appl. No.:
12/774659
Inventors:
Brent VAUGHAN - Kearns UT, US
Shane M. LEFLER - American Fork UT, US
Richard H. BENNETT - Captain Cook HI, US
Calvin M. McCAUSLAND - Springville UT, US
David LISONBEE - Orem UT, US
Shane M. LEFLER - American Fork UT, US
Richard H. BENNETT - Captain Cook HI, US
Calvin M. McCAUSLAND - Springville UT, US
David LISONBEE - Orem UT, US
Assignee:
4LIFE PATENTS, LLC - Sandy UT
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
A method for non-invasively assessing a subject's health includes evaluating a state of a subject's immune response. Such a method may include obtaining a salivary sample from the subject and assaying the salivary sample for IgA. The state of a component of the subject's immunity may be evaluated in conjunction with the administration of one or more substances known to elicit a cell-mediated immune response to the subject to determine the effect of the one or more substances on the subject's humoral, or antibody-mediated, immune response. Assay methods may also be used to optimize the dosage of an immune support component to be administered to a particular subject. Systems that include assays for evaluating the state of a subject's immune response and nutraceuticals are also disclosed.
Nanofraction Immune Modulators, Preparations And Compositions Including The Same, And Associated Methods
US Patent:
2008008, Apr 3, 2008
Filed:
Sep 14, 2007
Appl. No.:
11/855944
Inventors:
David Lisonbee - Orem UT, US
Calvin McCausland - Springville UT, US
Richard Bennett - Captain Cook HI, US
Brent Vaughan - Kearns UT, US
Shane Lefler - American Fork UT, US
Calvin McCausland - Springville UT, US
Richard Bennett - Captain Cook HI, US
Brent Vaughan - Kearns UT, US
Shane Lefler - American Fork UT, US
International Classification:
A61K 35/20, A61K 35/54, A61P 37/04, C12Q 1/02
US Classification:
424535000, 424581000, 435029000
Abstract:
Compositions that include extracts from sources of immune modulators that include nanofraction immune modulator molecules (i.e., molecules having molecular weights of about 3,000 Da and less) are disclosed. These compositions may also include other immune modulators, such as transfer factor. Administration of compositions with extracts that include nanofraction immune modulator molecules modulates the cell-mediated immunity (e.g., down-regulates undesired T cell activity) of a subject to which such compositions are administered. When administered with transfer factor, the combination of nanofraction immune modulator molecules and transfer factor down-regulates undesired T cell activity while increasing, or up-regulating, T cell activity against pathogens and other undesirable entities, such as cancer cells and other aberrant or mutated cells. Assays and assay techniques for evaluating the immune modulation capabilities of various substances are also disclosed.
Transfer Factor Preparations And Associated Methods
US Patent:
2007007, Mar 29, 2007
Filed:
May 2, 2006
Appl. No.:
11/415837
Inventors:
Calvin McCausland - Springville UT, US
Brent Vaughan - Kearns UT, US
David Lisonbee - Boise ID, US
William Hennen - Eagle Mountain UT, US
Brent Vaughan - Kearns UT, US
David Lisonbee - Boise ID, US
William Hennen - Eagle Mountain UT, US
International Classification:
A61K 36/889, A61K 36/87
US Classification:
424727000, 424766000, 424777000
Abstract:
A drink includes an edible liquid or semisolid preparation and transfer factor. The drink may also include lactoferrin and one or more preservatives. An edible preparation includes a fruit component and transfer factor. The fruit component may include at least one oligoproanthocyanidin-containing fruit. The edible preparation may also include lactoferrin. One or more preservatives may also be included in the edible preparation. The drink or the edible preparation may be sterilized or pasteurized.
Nutriceutical Gels
US Patent:
2010011, May 13, 2010
Filed:
May 5, 2009
Appl. No.:
12/436062
Inventors:
Brent M. Vaughan - Kearns UT, US
Calvin W. McCausland - Springville UT, US
David A. Lisonbee - Orem UT, US
Calvin W. McCausland - Springville UT, US
David A. Lisonbee - Orem UT, US
Assignee:
4LIFE PATENTS, LLC - Sandy UT
International Classification:
A61K 39/00, A61P 37/04
US Classification:
4241841
Abstract:
A nutriceutical food product includes a solid matrix and a liquid combined into a gel. The nutriceutical food product may include an immune modulator, such as transfer factor and/or a nanofraction immune modulator. A fruit component may be included in the nutriceutical food product. The fruit component may include at least one oligoproanthocyanidin-containing fruit, such as acai.